Purchase Order 75N95023P00304
Award Date 7/10/23
Potential Completion Date 1/9/24
Potential Value $53K
Funding Federal Agency
Contracting Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Gaithersburg, MD 20878, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Department of Health and Human Services National Institutes of Health Clinical Center awarded a $29,855 purchase order to Miltenyi Biotec, Inc. of Auburn, California. The firm fixed price order is for the delivery of Miltenyi Gentle MACS Octo Dissociator systems with heaters to the agency. The dissociator systems will be used at the NIH Clinical Center to support biomedical research activities from July 19, 2023 through September 30, 2023. No subcontractors or set aside designations were...
- The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $27,160 firm fixed price purchase order to Miltenyi Biotec, Inc. to deliver one Miltenyi gentleMACS Octo Dissociator with Heaters. The solicitation sought this brand name product to support research at the National Institutes of Health campus in Bethesda, Maryland. The contract period of performance runs from September 10, 2023 through December 30, 2023. No...
- The U.S. National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), awarded a $4,881.00 firm-fixed-price purchase order contract to Miltenyi Biotec, Inc., a global biotechnology company, for a GENTLEMACS DISSOCIATOR. This contract is not set-aside and has an ultimate completion date of September 16, 2015. Miltenyi Biotec is a prime contractor with significant experience supplying specialized laboratory instruments, reagents, and services to...
- The Department of Health and Human Services, National Institutes of Health (NIH), National Cancer Institute (NCI) awarded a $29,858 firm-fixed-price purchase order to Miltenyi Biotec, Inc. to provide one Miltenyi Biotec GentleMACS Octo Dissociator with heating units. The equipment will be used to support the work of the NCI's Center for Immuno-Oncology, Laboratory of Tumor Immunology and Biology. There was no set-aside designation for this procurement, and the contract completion date is July...
- This is a $5,143.50 firm-fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Miltenyi Biotec, Inc. for a GENTLEMACS DISSOCIATOR. The contract has no set-aside designation and was awarded on March 23, 2016 with a completion date of April 5, 2016. Miltenyi Biotec is a global biotechnology company that provides specialized scientific instruments, reagents, and services to support...
- The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $59,710 purchase order to Miltenyi Biotec, Inc. to deliver two GentleMACS Octo Dissociator units with heaters. The place of performance will be in Auburn, California, and the period of performance is from September 10, 2023 through December 30, 2023. This firm fixed price contract supports NIH/NIAID research efforts through the procurement of specialized...
- This is a $18,639.00 firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Miltenyi Biotec, Inc., a global biotechnology company that provides specialized scientific instruments, reagents, and services. The contract is for the delivery of Miltenyi's tissue dissociator and associated laboratory equipment. This award is part of a larger indefinite delivery contract (IDC) worth $2.3 million that Miltenyi Biotec holds with the NIH Clinical...
- The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $27,160 firm fixed price purchase order to Miltenyi Biotec, Inc. to deliver one GentleMACS Octo Dissociator with heaters. The product is needed to support research at the National Institutes of Health in Bethesda, Maryland. The solicitation sought this specific brand name product or an equal, to be provided by the prime contractor with no set aside...
- The Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $24,081.00 firm fixed-price purchase order to Miltenyi Biotec, Inc., a foreign-owned for-profit manufacturer, for a GENTLEMACS OCTO DISSOCIATOR WITH HEATERS scientific instrument and associated freight charges. The award does not utilize a set-aside designation. Miltenyi Biotec specializes in providing scientific instruments, bioreagents, and services to...
- This federal contract award to Miltenyi Biotec, Inc. is for the delivery of specialized laboratory equipment, reagents, and consumables to the National Institutes of Health (NIH) Clinical Center. The $5,406.00 firm-fixed-price purchase order includes products such as the GentleMACS Tissue Dissociation Kit and GentleMACS C Tubes, provided at no additional cost to the government. The award is part of a larger $2.3 million single-award indefinite delivery contract (IDC) that Miltenyi Biotec holds...
The Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences awarded a $53,451 purchase order to Miltenyi Biotec, Inc. of Potomac, Maryland. Under this firm fixed price contract, Miltenyi Biotec will provide GentleMACS Octo Dissociators with Heaters to the agency, supporting tissue dissociation needs, over a six-month period of performance from July 2023 through January 2024. No subcontractors or set-aside designations were identified. The National Center for Advancing Translational Sciences works to accelerate the development and testing of new diagnostics and treatments across a wide range of diseases and conditions.
Generated 12/20/23, 4:27 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $53.5k | 7/5/23 |